nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Bronchospasm—Pentoxifylline—systemic scleroderma	0.00724	0.00724	CcSEcCtD
Prilocaine—Respiratory failure—Mycophenolic acid—systemic scleroderma	0.00712	0.00712	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Captopril—systemic scleroderma	0.00667	0.00667	CcSEcCtD
Prilocaine—Neuropathy—Mycophenolic acid—systemic scleroderma	0.00657	0.00657	CcSEcCtD
Prilocaine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Prilocaine—Sweating—Pentoxifylline—systemic scleroderma	0.00629	0.00629	CcSEcCtD
Prilocaine—Bronchospasm—Mometasone—systemic scleroderma	0.00625	0.00625	CcSEcCtD
Prilocaine—Cardiac arrest—Captopril—systemic scleroderma	0.00614	0.00614	CcSEcCtD
Prilocaine—Neuropathy—Lisinopril—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Prilocaine—Swelling—Mycophenolic acid—systemic scleroderma	0.00575	0.00575	CcSEcCtD
Prilocaine—Lightheadedness—Lisinopril—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Prilocaine—Respiratory failure—Mycophenolate mofetil—systemic scleroderma	0.00562	0.00562	CcSEcCtD
Prilocaine—Injury—Mycophenolic acid—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Prilocaine—Bronchospasm—Captopril—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Prilocaine—Osteoarthritis—Leflunomide—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Prilocaine—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00526	0.00526	CcSEcCtD
Prilocaine—Cardiac failure—Mycophenolic acid—systemic scleroderma	0.0052	0.0052	CcSEcCtD
Prilocaine—Neuropathy—Mycophenolate mofetil—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Prilocaine—Osteoarthritis—Mycophenolic acid—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Prilocaine—Dermatitis atopic—Prednisone—systemic scleroderma	0.00505	0.00505	CcSEcCtD
Prilocaine—Tension—Pentoxifylline—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Prilocaine—Nervousness—Pentoxifylline—systemic scleroderma	0.00498	0.00498	CcSEcCtD
Prilocaine—Injury—Lisinopril—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Prilocaine—Hypoxia—Methotrexate—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Prilocaine—Vision blurred—Pentoxifylline—systemic scleroderma	0.00483	0.00483	CcSEcCtD
Prilocaine—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.00483	0.00483	CcSEcCtD
Prilocaine—Tremor—Pentoxifylline—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Prilocaine—Anaemia—Pentoxifylline—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00472	0.00472	CcSEcCtD
Prilocaine—Osteoarthritis—Lisinopril—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Prilocaine—Diplopia—Lisinopril—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Prilocaine—Paralysis—Methotrexate—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Prilocaine—Hypertension—Pentoxifylline—systemic scleroderma	0.00443	0.00443	CcSEcCtD
Prilocaine—Cyanosis—Methotrexate—systemic scleroderma	0.00442	0.00442	CcSEcCtD
Prilocaine—Injury—Mycophenolate mofetil—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Prilocaine—Anxiety—Pentoxifylline—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Prilocaine—Cardiac arrest—Lisinopril—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Prilocaine—Confusional state—Pentoxifylline—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Prilocaine—Oedema—Pentoxifylline—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Prilocaine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Prilocaine—Shock—Pentoxifylline—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Prilocaine—Cardiac failure—Mycophenolate mofetil—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Prilocaine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Prilocaine—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Prilocaine—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Prilocaine—Osteoarthritis—Mycophenolate mofetil—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Prilocaine—Hypotension—Pentoxifylline—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Prilocaine—Bronchospasm—Lisinopril—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Prilocaine—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Prilocaine—Tension—Captopril—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Prilocaine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Prilocaine—Nervousness—Captopril—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Prilocaine—Sweating—Mycophenolic acid—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Prilocaine—Somnolence—Pentoxifylline—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Prilocaine—Vision blurred—Captopril—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Prilocaine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Prilocaine—Anaemia—Captopril—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Prilocaine—Extravasation—Methotrexate—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Prilocaine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Prilocaine—Neuropathy—Prednisone—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Prilocaine—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Prilocaine—Syncope—Captopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Prilocaine—Arrhythmia—Azathioprine—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Prilocaine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Prilocaine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Prilocaine—Loss of consciousness—Captopril—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Prilocaine—Sweating—Lisinopril—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Prilocaine—Urticaria—Pentoxifylline—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Prilocaine—Dysarthria—Methotrexate—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Prilocaine—Arrhythmia—Leflunomide—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Prilocaine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Prilocaine—Paraesthesia—Mometasone—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Prilocaine—Bradycardia—Lisinopril—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Prilocaine—Euphoric mood—Prednisone—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Prilocaine—Confusional state—Captopril—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Prilocaine—Respiratory failure—Methotrexate—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Prilocaine—Anaphylactic shock—Captopril—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Prilocaine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Prilocaine—Anaemia—Azathioprine—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Prilocaine—Shock—Captopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Prilocaine—Pain—Mometasone—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Prilocaine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Prilocaine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Prilocaine—Vision blurred—Leflunomide—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Prilocaine—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Prilocaine—Asthenia—Pentoxifylline—systemic scleroderma	0.003	0.003	CcSEcCtD
Prilocaine—Tension—Mycophenolic acid—systemic scleroderma	0.003	0.003	CcSEcCtD
Prilocaine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Prilocaine—Hypotension—Captopril—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Prilocaine—Anaemia—Leflunomide—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Prilocaine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Prilocaine—Injury—Prednisone—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Prilocaine—Tinnitus—Lisinopril—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Prilocaine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Prilocaine—Tremor—Mycophenolic acid—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Prilocaine—Paraesthesia—Captopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Prilocaine—Arrhythmia—Lisinopril—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Prilocaine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Prilocaine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Prilocaine—Somnolence—Captopril—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Prilocaine—Cardiac failure—Prednisone—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Prilocaine—Dizziness—Pentoxifylline—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Prilocaine—Hypertension—Leflunomide—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Prilocaine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Prilocaine—Syncope—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Prilocaine—Anxiety—Leflunomide—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Prilocaine—Osteoarthritis—Prednisone—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Prilocaine—Tension—Lisinopril—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Prilocaine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Prilocaine—Nervousness—Lisinopril—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Prilocaine—Vomiting—Pentoxifylline—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Prilocaine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Prilocaine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Prilocaine—Feeling abnormal—Captopril—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Prilocaine—Vision blurred—Lisinopril—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Prilocaine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Prilocaine—Asthenia—Mometasone—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Prilocaine—Hypotension—Azathioprine—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Prilocaine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Prilocaine—Cardiac arrest—Prednisone—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Prilocaine—Tremor—Lisinopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Prilocaine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Prilocaine—Anaemia—Lisinopril—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Prilocaine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Prilocaine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Prilocaine—Oedema—Mycophenolic acid—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Prilocaine—Nausea—Pentoxifylline—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Prilocaine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Prilocaine—Syncope—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Prilocaine—Shock—Mycophenolic acid—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Prilocaine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Prilocaine—Hypotension—Leflunomide—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Prilocaine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Prilocaine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Prilocaine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Prilocaine—Paraesthesia—Leflunomide—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Prilocaine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Prilocaine—Anxiety—Lisinopril—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Prilocaine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Prilocaine—Vomiting—Mometasone—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Prilocaine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Prilocaine—Asthenia—Captopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Prilocaine—Osteoarthritis—Methotrexate—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Prilocaine—Confusional state—Lisinopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Prilocaine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Prilocaine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Prilocaine—Oedema—Lisinopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Prilocaine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Prilocaine—Pain—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Prilocaine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Prilocaine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Prilocaine—Shock—Lisinopril—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Prilocaine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Prilocaine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Prilocaine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Prilocaine—Nausea—Mometasone—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Prilocaine—Pain—Mycophenolic acid—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Prilocaine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Prilocaine—Hypotension—Lisinopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Prilocaine—Dizziness—Captopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Prilocaine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Prilocaine—Urticaria—Leflunomide—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Prilocaine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Prilocaine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Prilocaine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Prilocaine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Prilocaine—Paraesthesia—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Prilocaine—Vomiting—Captopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Prilocaine—Somnolence—Lisinopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Prilocaine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Prilocaine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Prilocaine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Prilocaine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Prilocaine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Prilocaine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Prilocaine—Pain—Lisinopril—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Prilocaine—Bradycardia—Prednisone—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Prilocaine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Prilocaine—Nausea—Captopril—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Prilocaine—Asthenia—Leflunomide—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Prilocaine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Prilocaine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Prilocaine—Dizziness—Azathioprine—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Prilocaine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Prilocaine—Urticaria—Lisinopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Prilocaine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Prilocaine—Vomiting—Azathioprine—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Prilocaine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Prilocaine—Drowsiness—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Prilocaine—Dizziness—Leflunomide—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Prilocaine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Prilocaine—Arrhythmia—Prednisone—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Prilocaine—Sweating—Methotrexate—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Prilocaine—Vomiting—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Prilocaine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Prilocaine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Prilocaine—Nausea—Azathioprine—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Prilocaine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Prilocaine—Asthenia—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Prilocaine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Prilocaine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Prilocaine—Nausea—Leflunomide—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Prilocaine—Vision blurred—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Prilocaine—Anaemia—Prednisone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Prilocaine—Dizziness—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Prilocaine—Nausea—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Prilocaine—Syncope—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Prilocaine—Tinnitus—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Prilocaine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Prilocaine—Loss of consciousness—Prednisone—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Prilocaine—Vomiting—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Prilocaine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Prilocaine—Hypertension—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Prilocaine—Anxiety—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Prilocaine—Nausea—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Prilocaine—Oedema—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Prilocaine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Prilocaine—Shock—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Prilocaine—Nervous system disorder—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Prilocaine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Prilocaine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Prilocaine—Vision blurred—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Prilocaine—Anaemia—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Prilocaine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Prilocaine—Paraesthesia—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Prilocaine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Prilocaine—Confusional state—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Prilocaine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Prilocaine—Feeling abnormal—Prednisone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Prilocaine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Prilocaine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Prilocaine—Urticaria—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Prilocaine—Hypotension—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Prilocaine—Paraesthesia—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Prilocaine—Somnolence—Methotrexate—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Prilocaine—Hypersensitivity—Prednisone—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Prilocaine—Asthenia—Prednisone—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Prilocaine—Pain—Methotrexate—systemic scleroderma	0.000954	0.000954	CcSEcCtD
Prilocaine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Prilocaine—Urticaria—Methotrexate—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Prilocaine—Dizziness—Prednisone—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Prilocaine—Vomiting—Prednisone—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Prilocaine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000822	0.000822	CcSEcCtD
Prilocaine—Asthenia—Methotrexate—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Prilocaine—Nausea—Prednisone—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Prilocaine—Dizziness—Methotrexate—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Prilocaine—Vomiting—Methotrexate—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Prilocaine—Nausea—Methotrexate—systemic scleroderma	0.000663	0.000663	CcSEcCtD
